Ferrer instructs Deloitte on Trommsdorff sale

Deloitte advised Spanish pharmaceutical group Ferrer on the sale of German medicine and food supplement manufacturer Trommsdorff to Dermapharm.


Dermapharm was advised by law firm P + P Pöllath + Partners, according to Mergermarket.

The transaction was reportedly worth more than €100 million.

Trommsdorff’s annual revenues are approximately €51 million. Meanwhile, Ferrer’s 2016 profits totalled €8.4 million.

Ben Cook